Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Good rebuttal. Nothing I said is opinion, it's all fact.
Series A analysis.
Exactly. Thanks for confirming EQ's gas lighting.
"If that transaction would have taken place with a NYSE or big Nasdaq company"
What transaction specifically are you referring to?
"not only would the stock have been immediately halted, but it would've made headline news on CNBC"
I thought maybe it'd be common sense that, regardless of what kind of transaction you're talking about above, a "NYSE or big NASDAQ company" presumably would have identified and worked out any issues prior to consummating said amorphous transaction.
"That preferred stock took virtually all rights from common shareholders."
Which shareholders? The holders of 69,042,293 common shares issued between consummation of what I presume is the transaction to which you refer above and the creation and issuance of the Series A? Or the folks who bought those shares following NSI's August 22, 2018, 8K notifying the general public of a "Material Modification to Rights of Security Holders?" Or, is it all holders of common shares in excess of 300,000,000 (remember Series A voting rights = 60 common : 1 Preferred) (NSI didn't exeed 300,000,000 O/S until the 2019-04-01 Prospectus. https://www.sec.gov/Archives/edgar/data/1465470/000165495419003865/nsmp_424b3.html).
Claims require harm. Which NSI shareholders were harmed and when? I'll indulge you since I'm feeling generous today.
2014-05-19
8-K noticing Delgado's ascension with majority purchase of shares in Multiplayer Online Dragon 97.94%
https://www.sec.gov/Archives/edgar/data/1465470/000114420414032068/v379005_8-k.htm
2014-07-14
Annual Report noticing Management's intent to look for merger and to change business plans.
https://www.sec.gov/Archives/edgar/data/1465470/000114420414042739/v383401_10k.htm
2014-12-03
"The Consideration will represent approximately 77.85% of the outstanding common stock of the Company immediately following the closing on a fully diluted basis."
https://www.sec.gov/Archives/edgar/data/1465470/000114420414071981/v395452_8-k.htm
2015-02-03
"NSH beneficially owns 75,520,240 shares of Common Stock, which represent approximately 88.62% of the outstanding shares of Common Stock. By reason being a director and the Chairman of the Board and Chief Executive Officer of NSH, Williams may be deemed to beneficially own 75,520,240 shares of Common Stock, which represent approximately 88.62% of the outstanding shares of Common Stock. By reason of being a director and the President and Secretary of NSH, Easterling may be deemed to beneficially own 75,520,240 shares of Common Stock.
(b) NSH has the sole power to vote and sole power to dispose of 75,520,240 shares of Common Stock, which represent approximately 88.62% of the outstanding shares of Common Stock. Williams and Easterling may be deemed to be the indirect beneficial owner of such shares under Rule 16a-1(a)(2) promulgated under the Exchange Act. However, pursuant to Rule 16a-1(a)(4) promulgated under the Exchange Act, Williams and Easterling disclaim that they are beneficial owners of such shares, except to the extent of their pecuniary interest herein."
https://www.sec.gov/Archives/edgar/data/1465470/000135448815000426/mod_sc13d.htm
Paragraph 3 of the JOINT Motion for Stipulation of Settlement of Claims states:
"On January 30, 2015, the asset purchase was consummated between NSI and NSH. Pursuant to the agreement, NSI issued 75,520,240 shares of common stock to NSH as consideration for all of the assets. As a result of the transaction, NSH held 88.62% of the issued and outstanding shares of NSI.
2015-02-23
"State the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date:
85,220,240 as of February 20, 2015"
https://www.sec.gov/Archives/edgar/data/1465470/000135448815000775/mod_10q.htm
Amended Exhibit A to the JOINT Motion for Stipulation of Settlement of Claims puts the number of common shares to be issued at
92,830,216.
2018-08-20
Just two days before issuance of the Series A, "[a]s of August 20, 2018, there were 154,262,533 shares of the registrant’s common stock outstanding."
https://www.sec.gov/Archives/edgar/data/1465470/000165495418009409/shmp_10q.htm
Paragraph 3 of the JOINT Motion for Stipulation of Settlement of Claims continued to state:
Subsequently, pursuant to the agreement with NSH shareholders and the representations made to them at the time, the NSI common shares were supposed to be exchanged for the privately held shares of NSH, some of which were held by Plaintiff, resulting in each shareholder of NSH getting the equivalent number of shares of the common stock of NSI. However, because of the complex securities laws, NSI/NSH was prohibited from being able to distribute the NSI shares acquired in the asset purchase directly to the NSH shareholders for several reasons, including the fact that the NSH shareholder group contained a large number of unaccredited shareholders, as that terms is defined under the securities laws, that greatly exceeded the allowable number under the regulations for a distribution at the time. Because the “going public” scenario was a goal of NSH, and one the shareholders were in favor of and had been promised over the years, the asset purchase was consummated/structured so that the Company could become public in the transaction and the NSI shares would be reserved for the NSH shareholders. While the Company sought solutions to the share exchange issue, in the interim, the NSI shares of common stock were to be held beneficially for the shareholders of NSH, including Plaintiff."
2018-08-22
Speaks for itself.
https://www.sec.gov/Archives/edgar/data/1465470/000165495418009491/shmp_8k.htm
Paragraph 4 of the JOINT Motion for Stipulation of Settlement of Claims continued to state:
"On August 15, 2018, NSH, which beneficially held the NSI shares for the NSH shareholders like Plaintiff, exchanged 75,000,000 shares of the common stock of NSI for 5,000,000 shares of newly issued Series A Preferred Stock, which had no rights to dividends— unlike the common shares. In addition, the Series A Preferred Shares were convertible into common shares with the consent of the majority of the holders of such shares. This was done with the goal of eventually making the shares more attractive for investors and a better market."
Who was harmed? Let's say it's "All of the Above," well, those common shareholders had the right to sue NSI since August 22, 2018, no? Gary Shover did. He did it on behalf of himself and others like him who, since they didn't have control of their shares until December 6, 2021 (Happy belated Anniversary), fall into ALL THREE categories discussed above. Consequently, any "investor" who could have standing, but was not part of the Shover Suit, nonetheless had their interests represented by Shover. This is why the outcome of the Shover Suit is applicable to all NSI "investors." The "issues" you raise were clearly adjudicated. This is not opinion, this is fact.
If you think the SEC can address some wrong, then:
1: Define the wrong to be addressed. All parts of this "transaction" were disclosed to the Public. Folks who bought NSI common shares after August 22, 2018, knew exactly what they were getting; and,
2. Define the statute of limitations for the cause of action. What law was violated? How long does the SEC have to address the violation? This is all statutory. You can make express citations. When should we expect the SEC to come in and address whatever violation you think occurred? We're into year six and crickets.
Unsophisticated U Darthium's original premise: "I am still waiting to read the required 8k from Natural Disaster exposing the Florida disaster."
What does the PL problem have to do with "the Florida Disaster"? Are we talking about the same things?
"For example, US Foods. Isn't it common sense that there are virtually no sales being generated from US Foods." How is this "fact" common sense? This is internal company information and the nature of their sales are not broken out. The general public literally has NO INFORMATION on which to conclude as you have, let alone call it "common sense."
"Isn't it common sense that even if Niterra was truly interested, isn't it common sense that Niterrq is in a much better position to negotiate a good deal as opposed to SHMP." This would be more in line with common sense. Based on facts, in the form of NUMBERS, NSI needs money to operate. Negotiation 101 says bargaining power will reside with the financier.
"Isn't it common sense that the company is in beyond deep financial trouble." This is not common sense. We know that NSI requires approximately $1 mil/mo. to operate. What is interesting is that the operation cost has not gone up between 10Q filings, while over the same time presumably production has increased. Therefore, if costs are relatively fixed in relation to production, then increased production gets you an economy of scale which has been economically unviable in the RAS industry to date. My point being, it's not common sense that NSI is in deep financial trouble IF production is increasing; increased accounts receivable should provide working capital sufficient to materially offset or do away with third-party financing.
"UF says someone would buy Fife out. Yes, maybe $200,000 at a time at 30 percent discounts. However and with the list of lawsuits that the SEC has against toxic lenders, I don't know anyone that would want to do it because the risk of an SEC lawsuit is great. Virtually every player that was in the toxic note business is gone."
NSI sells shares, Fife buys the shares and then may resell them. Under the last Financing Agreement, Fife is a middle-man Market Maker, not a lender. There' would be nothing to "buy out." Now, with regards to other financing arrangements between NSI and GHS, I would agree, there are set repayment terms / amounts which may require a "buy out." Not sure why lawsuits against "Toxic lenders" would prevent someone from "buying out" GHS's position. It's not like someone would be buying GHS and thus it's liabilities. This statement shows a severe lack of understanding of M&A / equity financing agreements.
Reliance on EQ's analysis of the SERIES A is misplaced.
How do you know NSI hasn't been getting the 2 million PL's/month? Where was this represented?
How many months ago? I very recently made a post about how, for me, the next 10Q will be pivotal to my position on whether I continue to give NSI the benefit of the doubt. For me, the March 2023 Homegrown PL contract answered a lot of questions regarding NSI's failure to meet its own represented production goals. IMO, it meant there were variables that made NSI's poor performance NOT SOLELY management's fault.
NOW, your comment implies that you and/or the general public have known about a Homegrown PL problem for months? NO ONE on this forum mentioned Homegrown PL problems in response to my very recent posts. Therefore, I find little credibility in the statement "news of the Homegrown issues were known many many months ago." Please provide factual support for how you get to this conclusion. The Homegrown Contract was signed end of March 2023, only 9 months ago. "Many many months ago" insinuates that the problem started almost IMMEDIATELY AFTER NSI signed the Homegrown Contract.
A worldwide PL problem makes me have to reevaluate my personal timeline for NSI.
Unsophisticated U Darthium thinks the termination of a LOI and the return of a $5000 deposit, on a deal that committed ZERO NSI funds and would develop ONLY with use of grant money, is a material event worth an 8K. LOL. That should tell you all you need to know.
figures have been represented. The data behind the figures, IMO, is proprietary.
"Total survival (%) 78"
That would make the mortality rate (100-78) 22%
You'll have to clarify what you mean by size distribution.
"Niterra has no skin in the SHMP game." I tend to agree with that statement.
I was referring specifically to Hydrenesis JV and Jefferson County JV. What are the other two you believe exist?
There are two Florida deals. Which one was GE referring to when he said we still have Florida?
Bro, they needed local, county and state funding. It was in conjunction with building an education center. AND, they only put down $5,000.00. As suspect of this company as you are, you can't tell me those facts made you think "Wow, this is the next big done deal!"
I don't disagree that there are unanswered questions. My issue is with the jumping to conclusions in the absence of information. Make a decision based on the absence of info, but don't speculate and pontificate as to what are believes the implications (always negative).
Funny how forward looking statements don't always pan out... like saying they'll never sell any shrimp...
Which of the PRs will NEVER come to fruition? Perhaps we have a patience problem, not a come to fruition problem.
Data has been released, some just don't believe in its accuracy or truthfulness. That's a personal decision to make, but again, it comes down to belief and speculation.
Fraud requires the misstatement to be material. EVERYONE knows the Florida deal was a long-shot; countless contingencies needed to be met by parties overwhich NSI had no control, including local, county and state governmental entities. Moreover, NSI had only $5,000.00 of skin in the game. I would say the loss of Florida is a far from material event for NSI, IMO. Wanna try again, UD?
Beliefs and assumptions is all I needed to know.
Such as? Just one. Prove just one tall tale. We all know the difference between puffery and intentional falsehoods, right?
And Management has made representations as to why to expect the types of reports that have been filed. You just choose to not believe those representations, which is your prerogative. But that begs the question: What proof and facts are you relying upon to form such an opinion?
If test results haven't been seen, then aren't you in the same boat as UF? If UF can't prove his position, then you can't prove yours either. Why so illogical? And don't give me your opinion on what you personally think should be happening as a result of the technology. I don't care to speculate with ignorant conjecture.
"On the one hand, Easterling months ago says finally we are buying 2,000,000 baby shrimp monthly, Q just announced says they sold 100,000 shrimp in three months ending Sep. Against 6,000,000 PLs...that is over 98% shrimp mortality rate...."
Grow is 24 weeks or 6 months. Therefore, first delivery of 2,000,000 PL per the March 2023 contract were NOT HARVESTABLE until at least last month. Therefore, NONE of the 2,000,000/month PL's are accounted for in this 10Q.
Failing to acknowledge this reality calls into question all the other analysis.
First, where does the 10Q say: "Fundamentally, NS is saying they sold $33K worth of shrimp and snuck in the $25K from Niterra as sales.."
I see: "Shrimp Sales... Six months ended... September 30, 2023... $55,872.00.
The $25,000 is accounted for in the "$175,000.00" for "Technology and equipment services"
Second, besides being off, your math requires we make assumptions that are not necessarily true.
If you haven't figured it out by now, I go with what the company represents. We have laws and causes of action that are supposed to protect investors and promote reasonable reliance on corporate / managerial representations. Up to this point, complaints about NSI management and financial health have reasonable explanations other than "scam."
However, NSI has omitted / not disclosed any PL supply issues since March 2023. Therefore, if the numbers in the next 10Q do not reflect what NSI has represented (a steady monthly supply of 2,000,000 PLs), then I am prepared to move into the "scam camp."
This is just mindboggling... along with leaving $3 million on the table since July 20, 2023.
With that said, about the sales... they are what I anticipated. NSI represented that it ran into issues with PL supply. October 2023 was the first month PLs from the March 2023 contract could be harvested. Therefore, this 10Q only covers a period where PL acquisition was presumably unstable.
The next 10Q will be my ultimate decider: the information therein being the best opportunity yet to indepenently evaluate the financial viability of the SHMP technology. If what NSI represented in the past is true, then sales in the next 10Q must reflect a steady supply of 2 million PL per month; a number which should be multiples above $58,000.00.
Yes. it's almost exactly 24 weeks since NSI announced the 2,000,000 PL contract in March.
I remember when the mantra was "zero sales." Now it's "almost zero sales." That alone is a notable development.
This "explanation" is really just an opinion. An opinion of a legal matter.... from a non lawyer.
Clearly you're not a laywer. Keep arguing with yourself.
You should read the Shover Complaint. Gary lays out all the facts that NSI did not contest and in fact stipulated to. You then should read Judge Kinkeade's Order Approving Stipulation for Settlement of Claims. From those two documents you should be able to draw your own conclusions.
Ha! We have a shared experience.
False. Read filings.
And I bet myself you'd have no meaningful, substantive explanation and I won.
You do realize that what you described is just simply OTC options trading, right? But please, teach me how the folks you describe are not folks who would short OTC stocks.
Ask him to define Market Maker
Check out NASD Rule 3360
Here's a nice SEC Notice discussing the interplay of SRO's and the SEC.
https://www.sec.gov/files/rules/sro/nasd/34-52679.pdf